PROFESSIONAL EXPOSURE TO TOXIC SUBSTANCES
- Overview
- Assessment methods
- Learning objectives
- Contents
- Full programme
- Teaching methods
- Contacts/Info
For the understanding of the topics covered during the course, basic knowledge of pharmacology and epidemiological methodology is useful.
The evaluation consists of an oral exam. The student will be asked some questions, one of which is his/her choice. One of the questions will focus on the proposed scenarios. The aim of the exam is to verify: 1. the level of achievement of the training objectives, evaluating the level of knowledge and in-depth study of the topics addressed; 2. full understanding of the methods and results of what has been achieved in UMaCa.
For the purposes of the evaluation, the teacher will take into account the student's ability to: articulate the speech with clarity, precision, relevance and propriety of language, make connections between the contents of the course and compare different aspects covered in class. The grade is expressed in thirtieths. The active and proactive participation in the classroom discussion is not evaluated for the purposes of the final grade, but is intended to provide students with the opportunity to increase awareness of their level of learning and the ability to self-evaluate in progress regarding the knowledge gradually acquired and the possible need for further study and study.
The teaching activity aims to provide students with the basics of the assessment of the risk of exposure to toxic substances in the professional field. Specifically, practical guidance and regulatory aspects on the handling and exposure of anticancer drugs will be provided.
1. INTRODUCTION TO CHEMICAL RISK
2. ONCOLOGICAL THERAPIES
3. RISK MANAGEMENT AND PREVENTION OF ERRORS IN THERAPY WITH ANTINEOPLASTIC DRUGS
4. RISK MANAGEMENT AND ERROR PREVENTION DURING THE HANDLING OF ANTIBLASTIC CHEMOTHERAPY DRUGS
1. INTRODUCTION TO CHEMICAL RISK: Prevention and Protection Measures
2. ONCOLOGICAL THERAPIES: Knowledge of chemotherapeutics; Pharmacology; Polychemotherapy schemes;
3. RISK MANAGEMENT AND PREVENTION OF ERRORS IN THERAPY WITH ANTINEOPLASTIC DRUGS: Recommendation 14; Management of the Pharmacy-Oncology-Hematology system;
4. RISK MANAGEMENT AND ERROR PREVENTION DURING THE HANDLING OF ANTIBLASTIC CHEMOTHERAPY DRUGS: Quality controls.
The course is based on lectures that use PPT set with images, diagrams.
To promote critical reflection and allow students the opportunity for self-evaluation, questions and evaluation of possible scenarios are proposed in the classroom.
The teacher is available in the classroom before and after the lessons, by appointment.